An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II

被引:400
作者
Hasper, Hester E.
Kramer, Naomi E.
Smith, James L.
Hillman, J. D.
Zachariah, Cherian
Kuipers, Oscar P.
de Kruijff, Ben
Breukink, Eefjan
机构
[1] Univ Utrecht, Dept Membrane Biochem, Bijvoet Ctr Biomol Res, Biomembrane Inst, NL-3584 CH Utrecht, Netherlands
[2] Univ Groningen, Dept Genet, Groningne Biomol Sci & Biotechnol Inst, NL-9750 AA Haren, Netherlands
[3] Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA
[4] Oragen Inc, Alachua, FL 32615 USA
[5] Banyon Biomarkers, Alachua, FL 32615 USA
关键词
D O I
10.1126/science.1129818
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Lantibiotics are polycyclic peptides containing unusual amino acids, which have binding specificity for bacterial cells, targeting the bacterial cell wall component lipid II to form pores and thereby lyse the cells. Yet several members of these lipid II - targeted lantibiotics are too short to be able to span the lipid bilayer and cannot form pores, but somehow they maintain their antibacterial efficacy. We describe an alternative mechanism by which members of the lantibiotic family kill Gram-positive bacteria by removing lipid II from the cell division site ( or septum) and thus block cell wall synthesis.
引用
收藏
页码:1636 / 1637
页数:2
相关论文
共 20 条
[1]   Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies [J].
Bonelli, RR ;
Schneider, T ;
Sahl, HG ;
Wiedemann, I .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (04) :1449-1457
[2]   Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic [J].
Breukink, E ;
Wiedemann, I ;
van Kraaij, C ;
Kuipers, OP ;
Sahl, HG ;
de Kruijff, B .
SCIENCE, 1999, 286 (5448) :2361-2364
[3]   Lipid II as a target for antibiotics [J].
Breukink, E ;
de Kruijff, B .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (04) :321-332
[4]   Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics [J].
Brötz, H ;
Josten, M ;
Wiedemann, I ;
Schneider, U ;
Götz, F ;
Bierbaum, G ;
Sahl, HG .
MOLECULAR MICROBIOLOGY, 1998, 30 (02) :317-327
[5]   Biosynthesis and mode of action of lantibiotics [J].
Chatterjee, C ;
Paul, M ;
Xie, LL ;
van der Donk, WA .
CHEMICAL REVIEWS, 2005, 105 (02) :633-683
[6]   Control of cell morphogenesis in bacteria: Two distinct ways to make a rod-shaped cell [J].
Daniel, RA ;
Errington, J .
CELL, 2003, 113 (06) :767-776
[7]   Identification, characterization and purification of the lantibiotic staphylococcin T, a natural gallidermin variant [J].
Furmanek, B ;
Kaczorowski, T ;
Bugalski, R ;
Bielawski, K ;
Bogdanowicz, J ;
Podhajska, AJ .
JOURNAL OF APPLIED MICROBIOLOGY, 1999, 87 (06) :856-866
[8]   Assembly and stability of nisin-Lipid II pores [J].
Hasper, HE ;
de Kruijff, B ;
Breukink, E .
BIOCHEMISTRY, 2004, 43 (36) :11567-11575
[9]   The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics [J].
Hsu, STD ;
Breukink, E ;
Tischenko, E ;
Lutters, MAG ;
de Kruijff, B ;
Kaptein, R ;
Bonvin, AMJJ ;
van Nuland, NAJ .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2004, 11 (10) :963-967
[10]   Bacterial wall as target for attack: Past, present, and future research [J].
Koch, AL .
CLINICAL MICROBIOLOGY REVIEWS, 2003, 16 (04) :673-+